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KEY MESSAGES
 Within a collaborative ADHD programme for children, participating GPs were positive about a quick and
specialist diagnostic process within secondary care.
 After an online course, GPs felt confident to start and monitor ADHD medication in children with uncompli-
cated ADHD.
 GPs were content about the collaboration between primary and secondary care.
ABSTRACT
Background: Most general practitioners (GPs) do not feel comfortable with diagnosing and treat-
ing children with attention deficit hyperactivity disorder (ADHD). This is problematic since ADHD
is a prevalent disorder and an active role of GPs is desired. In the Netherlands a collaborative
ADHD programme was established, comprising of shortened diagnostic assessment in specialized
mental healthcare followed by psycho-education in mental healthcare and pharmacological treat-
ment by pre-trained GPs.
Objectives: To explore the experiences of GPs regarding the diagnosis and treatment of children
with uncomplicated ADHD within this programme.
Methods: Semi-structured interviews with 15 GPs were conducted. The GPs participated in an
evaluation of the collaborative ADHD programme. Data was analysed using the principles of con-
stant comparative analysis.
Results: Most participating GPs expressed reluctance to diagnose ADHD themselves. The reluc-
tance was due to a lack of time, knowledge and experience. The GPs welcomed the collaborative
programme because it met their need for both quick and adequate diagnosis by a specialist.
Furthermore, an online ADHD course, offered by the programme, gave them the confidence to
start and monitor ADHD medication. Finally, they appreciated the possibility of consulting a spe-
cialist when necessary.
Conclusion: GPs preferred that ADHD was diagnosed by a specialist. In the context of the ADHD
collaborative programme, they felt competent and comfortable to start and monitor medication
in children with uncomplicated ADHD.
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Introduction
Attention deficit hyperactivity disorder (ADHD) is a
common disorder with an estimated worldwide preva-
lence of 5% in children and adolescents.[1] The three
key-symptoms of ADHD are inattention, hyperactivity
and impulsiveness. Adequate treatment has been
shown to benefit patients and their families by improv-
ing behavioural problems, and includes in most cases
the prescription of medication.[2] The diagnostic
assessment, treatment and follow-up most often takes
place in secondary care.[3] However, the large numbers
of children referred to secondary care result in long
waiting times.[4] In the meantime, GPs in the
Netherlands have started to contribute to diagnosing
ADHD and initiating ADHD medication.[5] It is, how-
ever, presumed that this does not provide children
and adolescents with ADHD with optimal healthcare.[6]
For instance, over diagnosing of ADHD is a well-known
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problem in primary care.[7] Also, inadequate medical
treatment and a shortage of systematic aftercare have
been described.[8,9] Moreover, there are uncertainties
about GPs’ involvement in the diagnosis and treatment
of children with ADHD. The Dutch multidisciplinary
guideline for ADHD in children, for instance, does not
describe the GPs’ role and does not give applicable
recommendations to GPs for diagnosing and/or treat-
ing children with ADHD.[6] Also, many GPs do not see
a role for themselves in ADHD care or do not feel com-
fortable with it.[10,11] In the light of the high preva-
lence, the long waiting times, and the GPs’
uncertainties it seems necessary to develop practical
methods in which GPs can contribute to the manage-
ment of children with uncomplicated ADHD (i.e. no
comorbidity, no severe family problems).
Therefore, a collaborative ADHD programme was
developed in the east of the Netherlands, the
Tornado programme, with diagnostics by secondary
and tertiary line specialists, and medication prescribed
and monitored by GPs. The goal of this programme
is to shorten the time of diagnostic assessment and
to give GPs a more prominent role in ADHD care in
close collaboration with psychiatry. Effectiveness and
efficiency of the programme are being investigated in
a cluster trial. If the ADHD programme is to be imple-
mented nationwide, a successful participation of GPs
is crucial.
This study, therefore, aimed to investigate GPs’
experiences with participation in the collaborative pro-
gramme regarding their role in the treatment of chil-
dren with uncomplicated ADHD in primary care.
Methods
Design and objectives
A qualitative approach was deemed appropriate to
understand GPs’ experiences with participation in a col-
laborative treatment programme for children with
ADHD, because of the explorative character of this
design.
Participants and setting
A non-randomized controlled before-after study (trial
registration number NTR2505) examined the effective-
ness and efficiency of a collaborative programme com-
pared to usual care for 6 to 18 year-olds suspected of
uncomplicated ADHD in the Netherlands.[12] Usual
care existed of a diagnostic assessment, medication
treatment, psycho-education, maybe combined with
behavioural parent training, within secondary care.
In the collaborative programme (Box 1), GPs referred
children with suspected ADHD to a secondary care
one-day-to-diagnosis service. In addition, GPs were
invited to participate in a one-hour online course
about ADHD.[13] When patients returned to their GP
with the diagnosis of uncomplicated ADHD and a medi-
cation advice, the GP started and monitored ADHD
medication. Parents received psycho-education in the
outpatient clinic.
For the qualitative study, all participating GPs
(n¼ 23) in the collaborative programme were
approached. A mixture of male and female GPs was
selected and invited. Among these were two GPs who
did not participate in the online course. All invited GPs
consented for an interview. After 15 interviews, no
new themes emerged and saturation was reached.
Data collection
The interviewer (GO) and his supervisors (LH, PL) were
not involved in outcomes evaluation of the collabora-
tive programme for targeted ADHD patients. All had a
Box 1. Outline of the collaborative ADHD programme.
1. GPs referred children with suspected ADHD to
secondary care for a one-day-to-diagnosis ser-
vice in a psychiatric outpatient clinic for chil-
dren and adolescents.
2. At the same time, the outpatient clinic invited
the GPs to participate in a one-hour online
course about ADHD. The course was devel-
oped by psychiatrists and a GP. The main aims
of the course were to provide information
• about the characteristics of ADHD, and
• how to start and monitor ADHD medication,
and
• how to deal with side effects.
3. In addition, the use of the ADHD-rating scale
was explained. This scale is a reliable question-
naire with 18 items about the DSM-IV symp-
toms of ADHD, used for diagnosing and
monitoring ADHD in children.[13]
4. When patients returned to their GP with the
diagnosis of uncomplicated ADHD and a
medication advice, the GP started and moni-
tored ADHD medication.
5. Parents received psycho-education in the out-
patient clinic.
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medical background. A trained medical student (GO)
conducted semi-structured interviews via telephone
(August to September 2011). An interview guide was
developed (Box 2). Interviews lasted approximately
30min, they were audiotaped, transcribed verbatim,
and anonymized.
Analysis
Data collection and analysis were conducted as an
iterative process which means that relevant topics
were added to the guidebook after a preliminary ana-
lysis of each interview.[14] Data were entered into
Atlas.ti, a software package to support the analysis of
qualitative data. According to the principles of con-
stant comparative analysis in which transcripts are sub-
sequently coded thematically, transcripts were read
and re-read to identify relevant themes. The inter-
viewers had a biomedical perspective regarding ADHD
as a disorder that frequently needs pharmacological
treatment while at the same time recognizing psycho-
social aspects. A first categorization was made inde-
pendently by coding meaningful sentences. These
initial codes were discussed and grouped into themes
to identify GPs’ views on diagnosis and treatment of
children with uncomplicated ADHD in primary care
within the collaborative programme. In the case of not
reaching consensus about the codes, a third researcher
was consulted.
Results
We interviewed 15 GPs (seven females). The GPs had a
mean working experience of 12.5 years (range: 5–29
years). On average, each GP treated 1.3 children with
ADHD (range: 0–4) within 10 months. Two GPs had not
participated in the online ADHD course. One did not
want to participate in additional courses for all sorts of
health problems; the other one had time constraints.
Their views were not different from other GPs’ views.
We categorized the results in two main themes, in line
with the pre-existing interview guide: (a) GPs’ views
about their role in the diagnosis and treatment of chil-
dren with ADHD; (b) GPs’ experiences with the
pharmacological treatment of children with ADHD.
GPs’ views on their role in the diagnosis and
treatment of children with ADHD
Interviewed GPs preferred a specialist to diagnose
ADHD. Most did not see a role for themselves in the
diagnosis of ADHD. They mentioned some barriers: (a)
they do not feel sufficiently competent due to a lack
of knowledge and experience; (b) they think they have
too little time to collect all required information of
parents and teachers; and (c) they feel that the diag-
nostic assessment has to be done very precisely
because of the consequence, the prescription of psy-
choactive medication in children. Some GPs expressed
resistance towards prescribing stimulant medication for
Box 2. Interview guide.
In general
1. What was your main reason for participation in the collaborative programme?
2. Did the programme meet your expectations?
Online ADHD course
1. What is your overall opinion about the online ADHD course?
2. What pros and cons can you mention?
3. Did you feel competent to prescribe and monitor ADHD medication after having completed the
course?
GP’s experiences with treatment of children with uncomplicated ADHD
1. What were your experiences in the collaboration with secondary care within this programme?
2. How do you think about the use of the ADHD rating scale?
3. What kind of barriers did you perceive in the treatment of ADHD or within the collaborative
programme?
4. What is your perspective on treatment by a GP rather than a psychiatrist? What pros and cons can you
mention?
Diagnosis and treatment of ADHD in general
1. What is your view on the GPs’ role in the diagnostic assessment of children suspected of ADHD?
2. What is your view on the GPs’ role in the treatment of children with ADHD?
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children. Overcoming this resistance first requires an
adequate ADHD diagnosis.
I think it is quite complicated to ensure that the burdens
which parents have and they therefore present, such as
the symptoms of their children, do not mean that you as
a GP might establish a diagnosis too easily and so
perhaps more easily treat a child with medication than is
strictly speaking necessary. (GP-15, male)
As it involves psycho-stimulant medication that you give
to young children [. . .] I would like to be supported by
an expert, with validated questionnaires and so forth
and on top of this yet another good observation. [. . .] At
present I would like that piece of diagnostics to be
performed by the psychiatrist. (GP-05, male)
A minority of GPs thought they could diagnose
ADHD themselves, especially when supported by spe-
cific questionnaires or clear criteria. They regarded
their longstanding relationships with children and
their parents as very helpful in the diagnostic
process.
On the face of it I could perform the diagnostics.
However, GPs must have sufficient knowledge but also
sufficient possibilities, for example properly validated
questionnaires. An extensive psychological investigation is
not always necessary. Sometimes a good observation is
also enough. (GP-06, female)
I think that what psychiatrists pick up in a day we can
also pick up over a period of several years. Of course, we
see some patients frequently over a long period of time.
(GP-13, female)
Nevertheless it is a medicine that influences the brain
and functioning of a child, they belong to a vulnerable
group. I, therefore, think it is important to perform the
diagnostics well [. . .] If it is more complex then I think
the diagnostics should be performed by a specialist. But
if it seems a very. . . well, straightforward case of ADHD
[. . .], then I believe it can sometimes be diagnosed in
general practice. (GP-09, female)
All interviewed GPs saw a role for themselves in the
pharmacological treatment of children with uncompli-
cated ADHD. By playing a substantial role in the treat-
ment, they hoped this would save time in secondary
care with subsequently decreasing waiting times for
patients who need secondary care. Psycho-education for
parents costs too much time within general practice and
requires specific expertise, according to the GPs. Some
GPs thought that a practice nurse could have a role in
the diagnosis and treatment of children with ADHD.
I think the GP is perfectly able to perform the treatment.
I also think that should be the case . . . because it is less
burdensome for the children to come to the general
practitioner for a check-up than to a child psychiatrist.
(GP-06, female)
I think that there are particular benefits of treating the
patient in primary care. After all, it is a sort of
hospitalization of young children. That is why I am
reticent about sending all sorts of children to the
psychiatrist just like that. . . because by doing that you
are very much sticking labels on children who are still
quite young. [. . .] It is far less onerous if primary care is
allowed to play a bigger role. (GP-14, male)
An advantage of pharmacological ADHD treatment in
primary care is, according to the GPs, the low threshold
for patients and their parents. Most GPs have good,
mostly longstanding relationships with children and their
families. They thought it felt less stigmatizing for both
patients and parents to visit a GP than to visit a psych-
iatrist. In addition, GPs considered the short distance to
the practice as an advantage for patients. As a disadvan-
tage of ADHD treatment by a GP instead of a psychiatrist,
some GPs mentioned their lower competence due to
their lack of experience. Therefore, in difficult cases,
patients get advice only after the GP has consulted a
psychiatrist. Furthermore, GPs usually have only limited
contacts with other professionals who are often involved
in ADHD care for children.
It is also nice for both parents and children that they do
not have to go to a specialist outpatient’s clinic. That
saves them time . . . I think it is also pleasant for the
general practitioner to do. And I think that for patients,
in particular, it is much less of a threshold than a visit to
a psychiatrist. (GP-07, male)
It is of course a fantastic service that children can be
seen within one month. That would normally take
months when considering the long waiting lists. That is
definitely a big advantage. However, I can imagine that
the advantage will spread further if I have more
patients. . . so that I can gain some more experience.
(GP-11, female)
[A disadvantage is that] for more complex questions or
issues, there is not an immediate answer, I first need to
consult a specialist. (GP-09, female)
GPs’ experiences with the pharmacological
treatment of children with ADHD
Overall, participating GPs supported the rationale of a
shortened diagnostic assessment within secondary care
and, when necessary, subsequent pharmacological
treatment within primary care. According to the GPs,
the project met their expectations. GPs were content
about the collaboration with psychiatry, in particular
with the shortened diagnostic procedure including
short waiting lists, an adequate diagnosis and the abil-
ity to consult a psychiatrist. GPs said they found the
collaborative programme well organized. Some
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interviewed GPs complained that patients already
returned before they had participated in the online
course.
Some said they consulted a psychiatrist for advice
during treatment, mostly about doses, side effects or
switching to long-acting methylphenidate. Although it
was often difficult to contact a psychiatrist by tele-
phone, they felt helped very well by the psychiatrists.
Participating GPs said that they felt confident and
competent after the online course to start and monitor
ADHD medication in children. GPs said that the course
had been especially educative about the pharmaco-
logical treatment, for instance, medication dosing
schemes and side effects. In addition, they had
received a clear structure for follow-up consultations.
Some GPs felt the lack of treatment experience as a
small barrier. They emphasized their confidence in
gaining more experience when providing pharmaco-
logical treatment to more patients. A special ADHD
guideline for GPs would support them in the treat-
ment, they stated.
Pharmacological treatment is certainly not a problem.
We measure, we observe, we enquire about side effects
. . . we ask how it is going. . . (GP-12, male)
You treat children with the medicine that influences their
behaviour and that is still something very unnatural for
us. The publication of an official guideline would
certainly help overcome some of those reservations. (GP-
14, male)
I admit. . . psychiatry is, of course, more expert at the
moment. But I also think that with such collaboration it
could eventually work fine in a very different manner.
(GP-13, female)
GPs who had used the ADHD rating scale consid-
ered it a feasible instrument to monitor the course and
severity of ADHD symptoms. The scale offered them a
good structure for follow-up consultations.
Discussion
Main findings
Participating GPs felt comfortable with a new collab-
orative programme for children with uncomplicated
ADHD in which diagnosis and psycho-education
takes place in secondary care, and medication treat-
ment takes place in primary care. Participants wel-
comed the programme for several reasons. First, it
met their need for adequate diagnostics, which they
regarded as complicated but essential because of
the consequence of psycho-stimulant medication.
They appreciated the shortened access for the diag-
nostic assessment in secondary care. Second, partici-
pants felt equipped to start and monitor ADHD
medication in children, after having completed the
provided one-hour online course about ADHD. They
considered treatment within primary care feasible
and comfortable for patients and their parents
because of the familiarity and proximity of GPs.
Finally, participants were satisfied with the consult-
ation possibilities with psychiatrists in secondary
care when necessary.
Strengths and limitations
In the Netherlands, GPs provide more than 90% of
medical care themselves, both for adults and children.
Patients, including children, can only have access to
secondary care after being referred by their GP. With
GPs as gatekeepers, active cooperation exists between
Dutch primary and secondary care. This restriction
creates an opportunity for more intense collaboration
between primary and secondary care. Collaborative
projects, therefore, are characteristic for healthcare
systems with GPs as gatekeepers. Collaborative care
has been well organized and financed for some
chronic diseases for instance, diabetes mellitus.
Currently, primary and secondary care GPs are actively
looking for ways to share ADHD care for children.
GPs’ experiences within a formal collaborative ADHD
programme had not been investigated before.
Qualitative research has been recommended as the
best method to explore and clarify participants’ opin-
ions.[14] By using a cyclical and interactive way of
collecting and analysing data, we were able to per-
form an in-depth exploration of GPs’ views.[15] Data
saturation was reached.
An important limitation of this study is that we
used a convenience sample. Participants might have
had an above average interest in ADHD because
they had consented to participate in an ADHD pro-
gramme. Therefore, certain specific viewpoints could
have been left out of sight in this study and the
results might be more positive than we would have
found within a wider group of GPs. However, most
participants did not propagate ADHD diagnostics to
be carried out in primary care. This fits in with opin-
ions of average GPs in earlier research. Also, some of
our interviewed GPs mentioned they had not deliber-
ately chosen to participate in the programme. They
were simply asked by secondary care to do the
online ADHD course and then treat patients who
were referred to them.
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Comparison with existing literature
Our findings contradict earlier research that showed that
GPs did not feel confident to provide ADHD care.[10,11]
Australian GPs, for instance, only saw a role for the GP in
the monitoring of ADHD medication.[16] Other research
showed that GPs did not have adequate knowledge
about ADHD.[17,18] Education programmes have been
advised to increase GPs’ knowledge and confidence with
ADHD care.[4,10,19] Our collaborative programme—
including a brief online course—might meet this need,
because the GPs in our study felt comfortable and com-
petent not only in monitoring ADHD treatment in chil-
dren but also in initiating ADHD medication. Moreover,
they said they were willing to provide ADHD treatment
on a larger scale. Therefore, the Dutch collaborative
ADHD programme could be a model that facilitates
effective involvement of GPs in ADHD care. Furthermore,
it might meet the need for improvement of follow-up
care. Dutch researchers showed that 19% of children
using ADHD medication did not receive any follow-up
care.[8]
The resistance of participating GPs towards diagnos-
ing ADHD is in agreement with barriers mentioned in
earlier research: diagnostic complexity, time constraints
and concerns about stimulant medication.[11]
Furthermore, the ability to recognize ADHD correctly in
primary care seemed rather poor.[19] The extensive
rates of disorders that are comorbid with ADHD pose
special challenges to establishing an adequate diagno-
sis. It has been estimated that two in three children
with ADHD meet criteria for one or more coexisting
psychiatric disorder.[20]
Implications for general practice
The optimism of the participating GPs about their
role in the pharmacological treatment of children
with uncomplicated ADHD within a collaborative
programme is encouraging because general practice
is a more comfortable setting for children than the
psychiatric setting. Dutch GPs mostly know the
child’s family, and have extensive medical informa-
tion of the child available. They have practice
nurses who might help to provide parents with psy-
chological support. By involving GPs in ADHD care,
referral times for diagnostic assessments are
expected to reduce and the start of treatment to
be accelerated. Early treatment is relevant in a
period of children’s lives because postponing treat-
ment could lead to a lost year at school. GPs think
that a practical primary care guideline on ADHD
would help them in the pharmacological treatment.
Such a guideline has recently been developed by
the Dutch College of GPs, mainly because GPs are
asked more and more frequently to monitor ADHD
medication after diagnosis and initiation of medica-
tion in secondary care.[21] The added value of the
collaborative ADHD programme comprises the quick
referral for a one-day specialist diagnosis and subse-
quently faster start of appropriate treatment within
primary care. The ADHD guideline then helps GPs
to start and monitor treatment adequately.
Altogether, this can decrease over and under diag-
nosing of ADHD. Further, it can increase systematic
monitoring, which is desirable since Dutch GPs pro-
vide 61% of the repeat prescriptions of ADHD
medication.
Future research must show whether GPs can effect-
ively initiate ADHD medication themselves and
whether this will lead to a treatment shift to primary
care – and thus shortened waiting lists of child mental
health institutions. Effective prescribing is being inves-
tigated in the before mentioned cluster trial. When this
appears positive, broader implementation of a collab-
orative ADHD programme seems inevitable: according
to the GPs in this study, the willingness to diagnose
ADHD is absent in most GPs, whereas the willingness
to treat ADHD is present.
Conclusion
Participating GPs in a collaborative programme for chil-
dren with uncomplicated ADHD were positive about
their role in the medication treatment of these chil-
dren. GPs were happy with the diagnostic process
being performed in secondary care. After an online
course, they felt confident to provide treatment, and
they were content about the collaboration with sec-
ondary care.
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